Recent industry analysis gathered from our database Current Agreements, showcases a high volume of dealmaking activity in the distribution deal type among the pharma and biotech companies worldwide. Read the full story

PELOBIOTECH to Distribute ReachBio LLC's Products in Germany, Austria and Switzerland Read the full story

Par Pharmaceutical has entered into an exclusive acquisition and pharma licensing agreement with Handa Pharmaceuticals to acquire Handa's Abbreviated New Drug Application for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR Read the full story

The Apothecary Shops Specialty Pharmacies has received distribution rights from pharmaceutical manufacturer Pfizer for its new drug Inlyta (axitinib), and will begin to provide this new drug to patients immediately.  Read the full story

Thermo Fisher Scientific announced an agreement with global healthcare provider Abbott Laboratories to make its Procalcitonin (PCT) assay available with Abbott’s immunochemistry analyzers Read the full story

GlaxoSmithKline signed up three companies to distribute its portfolio of vaccines in China. Each of the three companies will be responsible for a specific geographical region of the PRC. Read the full story

The Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies. Read the full story